Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit

被引:0
|
作者
Mascarella, Marco Antonio
Olonisakin, Tolani
Rumde, Purva
Vendra, Varun
Nance, Melonie
Kim, Seungwon
Kubik, Mark
Sridharan, Shaum
Ferris, Robert
Fenton, Moon
Clayburgh, Daniel
Ohr, James
Sen, Malabika
Joyce, Sonali
Herman, James
Grandis, Jennifer
Zandberg, Dan
Duvvuri, Umamaheswar
机构
关键词
D O I
10.1158/1538-7445.AM2023-4338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4338
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy
    Smussi, Davide
    Mattavelli, Davide
    Paderno, Alberto
    Gurizzan, Cristina
    Lorini, Luigi
    Romani, Chiara
    Bignotti, Eliana
    Grammatica, Alberto
    Ravanelli, Marco
    Bossi, Paolo
    CANCER TREATMENT REVIEWS, 2023, 121
  • [42] Targeted therapies in head and neck cancer
    Pol M. Specenier
    Jan B. Vermorken
    Targeted Oncology, 2007, 2 : 73 - 88
  • [43] NOVEL NEOADJUVANT IMMUNOTHERAPY REGIMEN SAFETY AND SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CANCER
    Wolf, Gregory T.
    Fee, Willard E., Jr.
    Dolan, Robert W.
    Moyer, Jeffrey S.
    Kaplan, Michael J.
    Spring, Paul M.
    Suen, James
    Kenady, Daniel E.
    Newman, Jason G.
    Carroll, William R.
    Gillespie, M. Boyd
    Freeman, Scott M.
    Baltzer, Lorraine
    Kirkley, Terry D.
    Brandwein, Harvey J.
    Hadden, John W.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1666 - 1674
  • [44] Neoadjuvant chemotherapy: survival benefit in gastric cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (06): : E307 - E307
  • [45] NEOADJUVANT CHEMOTHERAPY IN HEAD AND NECK-CANCER
    FREI, E
    ERVIN, T
    MORTON, D
    CLARK, J
    FALLON, B
    CANCER DRUG DELIVERY, 1986, 3 (01): : 58 - 58
  • [46] Response to neoadjuvant radiation therapy for rectal cancer improves survival
    Castaldo, Eric T.
    Pinson, C. Wright
    Feurer, Irene D.
    Merchant, Nipun
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : S70 - S70
  • [47] Improvement of Survival With Response to Neoadjuvant Radiation Therapy for Rectal Cancer
    Castaldo, Eric T.
    Parikh, Alexander A.
    Pinson, C. Wright
    Feurer, Irene D.
    Merchant, Nipun B.
    ARCHIVES OF SURGERY, 2009, 144 (02) : 129 - 134
  • [48] Survival Benefit of Adjuvant Therapy for Resectable Pancreatic Cancer (PC) Patients Treated with Neoadjuvant Therapy
    Duelge, K.
    Krepline, A. N.
    Mahmoud, A.
    George, B.
    Ritch, P. S.
    Erickson, B. A.
    Quebbeman, E. J.
    Turaga, K. K.
    Johnston, F.
    Gamblin, T. C.
    Christians, K. K.
    Evans, D.
    Tsai, S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S102 - S102
  • [49] Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI
    Erstad, Derek J.
    Sojoodi, Mozhdeh
    Taylor, Martin S.
    Jordan, Veronica Clavijo
    Farrar, Christian T.
    Axtell, Andrea L.
    Rotile, Nicholas J.
    Jones, Chloe
    Graham-O'Regan, Katherine A.
    Ferreira, Diego S.
    Michelakos, Theodoros
    Kontos, Filippos
    Chawla, Akhil
    Li, Shen
    Ghoshal, Sarani
    Chen, Yin-Ching Iris
    Arora, Gunisha
    Humblet, Valerie
    Deshpande, Vikram
    Qadan, Motaz
    Bardeesy, Nabeel
    Ferrone, Cristina R.
    Lanuti, Michael
    Tanabe, Kenneth K.
    Caravan, Peter
    Fuchs, Bryan C.
    CLINICAL CANCER RESEARCH, 2020, 26 (18) : 5007 - 5018
  • [50] Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy
    Denkert, Carsten
    Darb-Esfahani, Silvia
    Loibl, Sibylle
    Anagnostopoulos, Ioannis
    Joehrens, Korinna
    SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (04) : 341 - 351